National Planning Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-26,221
Closed -$1.67M 104
2017
Q3
$1.67M Sell
26,221
-984
-4% -$57.5K 0.14% 162
2017
Q2
$1.53M Sell
27,205
-3,510
-11% -$191K 0.12% 196
2017
Q1
$1.66M Buy
30,715
+1,212
+4% +$66.5K 0.13% 177
2016
Q4
$1.49M Buy
29,503
+6,098
+26% +$333K 0.12% 185
2016
Q3
$1.23M Sell
23,405
-6,379
-21% -$410K 0.1% 205
2016
Q2
$2.23M Sell
29,784
-8,658
-23% -$612K 0.17% 124
2016
Q1
$2.74M Sell
38,442
-18,929
-33% -$1.19M 0.24% 93
2015
Q4
$3.42M Buy
57,371
+18,175
+46% +$1.2M 0.28% 83
2015
Q3
$2.57M Sell
39,196
-500
-1% -$31.7K 0.24% 91
2015
Q2
$2.49M Buy
39,696
+424
+1% +$27.9K 0.22% 100
2015
Q1
$2.55M Sell
39,272
-14,428
-27% -$903K 0.23% 99
2014
Q4
$3.18M Sell
53,700
-9,091
-14% -$513K 0.23% 82
2014
Q3
$3.19M Buy
62,791
+4,594
+8% +$229K 0.24% 80
2014
Q2
$2.82M Buy
58,197
+657
+1% +$32.4K 0.22% 88
2014
Q1
$2.97M Buy
57,540
+781
+1% +$41.6K 0.26% 76
2013
Q4
$3.02M Buy
56,759
+2,707
+5% +$138K 0.27% 80
2013
Q3
$2.55M Buy
54,052
+8,751
+19% +$384K 0.25% 89
2013
Q2
$2.02M Buy
+45,301
New +$1.97M 0.25% 94

Other funds holding BMY

National Planning Corporation's BMY Position: Q4 2017 in Review

National Planning Corporation sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 26,221 shares — an estimated $1.67M sold.

National Planning Corporation first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $3.42M in Q4 2015. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • National Planning Corporation reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 26,221 Bristol-Myers Squibb shares in Q4 2017, an estimated $1.67M.
  • National Planning Corporation first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Bristol-Myers Squibb position peaked at $3.42M in Q4 2015.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.